[LB] Late Breaking Symposium

[LB-7] A dual dopaminergic modulation with L-DOPA and chlorpromazine for the treatment of primary dystonia

Hideki Shimazu^1,4, Shinichi Matsumoto², Hidetaka Koizumi³, Satoshi Goto^5,6, Masatoshi Koga⁵, Ryo Itabashi⁶, Yusuke Yakushiji⁷, on behalf of the ACUTE-PRAS Investigators (1.Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women’s University, Japan, 2.Department of Neurology, Osaka Neurological Institute, Japan, 3.Department of Neurology, Kyoto Prefectural Rehabilitation Hospital for the Disabled, Japan, 4.Department of Neurology, Itsuki Hospital, Japan, 5.Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University, Japan, 6.Center for Drug Discovery and Development Sciences, Research Organization of Science and Technology, Ritsumeikan University, Japan, 7.Department of Neurology, Kansai Medical University, Japan)